ProteKt secures funding for PKR kinase inhibitor-based therapies
Israeli biotech company ProteKt Therapeutics, which is focused on developing new PKR kinase inhibitor-based therapies for Alzheimer's Disease and other neurodegenerative diseases, has secured $3.6 ... Read More
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More
Novartis’ Sandoz to acquire Aspen’s Japanese pharma business
Sandoz, the generic drug business of Novartis has agreed to acquire the Japanese business of Aspen Global Incorporated (AGI), a fully owned subsidiary of Aspen ... Read More
F2G gets olorofim breakthrough therapy status from FDA for mold infections
F2G has secured breakthrough therapy designation to olorofim (formerly F901318) from the US Food and Drug Administration (FDA) for the treatment of certain invasive mold ... Read More
F2G gets olorofim breakthrough therapy status from FDA for mold infection
F2G has secured breakthrough therapy designation to olorofim (formerly F901318) from the US Food and Drug Administration (FDA) for the treatment of invasive mold infections. ... Read More
Chinese biopharma company Akeso raises $150m for antibody drug discovery
Akeso, a Chinese biopharma company engaged in antibody drug discovery and development in oncology and immunology therapeutic areas, has raised nearly $150 million through a ... Read More
Celgene, Acceleron bag Reblozyl FDA approval for anemia in beta thalassemia
Reblozyl FDA approval : Celgene and Acceleron Pharma have bagged approval from the US Food and Drug Administration (FDA) for Reblozyl (luspatercept-aamt) for the treatment ... Read More
WIRB-Copernicus acquires clinical trial consultant Waife & Associates
WIRB-Copernicus Group (WCG), a clinical services organization, said that its clinical services division has acquired Waife & Associates (W&A), a provider of management consulting services ... Read More
WIRB-Copernicus acquires clinical trial consultant Waife & Associates
WIRB-Copernicus Group (WCG), a clinical services organization, said that its clinical services division has acquired Waife & Associates (W&A), a provider of management consulting services ... Read More
Yuhan Pharmaceuticals to use Cyclica’s AI-driven drug discovery platform
Yuhan Pharmaceuticals has entered into a collaboration with Canadian biotechnology company Cyclica to use the latter's artificial intelligence (AI) driven integrated drug discovery platform in ... Read More